SEC Form 4 · accession 0001193125-26-365107
TEVA PHARMACEUTICAL INDUSTRIES LTD · TEVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronit Satchi-Fainaro
Director
Period of report
Aug 21, 2026
Accepted (ET)
Aug 25, 2026 · 4:03 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000818686
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Aug 21, 2026 | S | 415 | $37.25 | D | 111,986 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.